☆ 4.6 Editorial Material

Keratinocytes as drivers of hidradenitis suppurativa inflammation: need for priming

BRITISH JOURNAL OF DERMATOLOGY (2023)

Related references

Note: Only part of the references are listed.
Article Dermatology

Keratinocytes and immune cells in the epidermis are key drivers of inflammation in hidradenitis suppurativa providing a rationale for novel topical therapies

Stephanie L. Schell et al.

Summary: This study compares keratinocyte and immune cell-driven epidermal inflammation in HS patients and healthy controls. It demonstrates that interactions between keratinocytes and immune cells drive a broad inflammatory profile in HS epidermis. Ruxolitinib, a JAK inhibitor, mitigates inflammatory cytokine expression in HS lesional keratinocytes, suggesting its potential as a topical treatment for HS.

BRITISH JOURNAL OF DERMATOLOGY (2023)

Add to Collection
Article Dermatology

Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum

Kristina Navrazhina et al.

Summary: This study reveals that brodalumab, a human anti-IL-17 receptor A monoclonal antibody, effectively reduces inflammation and improves related pathways in Hidradenitis suppurativa (HS) patients. The response to treatment is best assessed in perilesional skin, and baseline expression levels of LCN2 and IL-17A can be used as predictive biomarkers for treatment response.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Add to Collection
Article Dermatology

Janus kinase 1 inhibitor INCB054707 for patients with moderate-to-severe hidradenitis suppurativa: results from two phase II studies

Afsaneh Alavi et al.

Summary: This study described the safety and efficacy results of the JAK1 inhibitor INCB054707 in patients with moderate-to-severe HS. The results showed that the drug was well tolerated and demonstrated therapeutic effects in patients with moderate-to-severe HS. These findings provide proof of concept for the use of JAK1 inhibitors in the treatment of HS.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Add to Collection
Article Cell Biology

Transcriptomic analysis of hidradenitis suppurativa skin suggests roles for multiple inflammatory pathways in disease pathogenesis

Beth E. Rumberger et al.

INFLAMMATION RESEARCH (2020)

Add to Collection
Article Dermatology

MABp1 Targeting IL-1α for Moderate to Severe Hidradenitis Suppurativa Not Eligible for Adalimumab: A Randomized Study

Theodora Kanni et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)

Add to Collection
Article Multidisciplinary Sciences

Compartmentalized Cytokine Responses in Hidradenitis Suppurativa

Theodora Kanni et al.

PLOS ONE (2015)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.